Skip to main content
. 2010 Nov 11;16:2362–2367.

Table 3. Overview of the HLAMatchmaker-derived histotocompatibility assessments in both cohorts.

Factor Cohort 1 (n=586) Cohort 2 (n=975)
Eplet mismatches HLA-A/B
20±9
17±10
Eplet mismatches HLA-DR
14±7
13±8
Tolerogenic factor (see Equation 1) −242±415 −182±408

Maximum of eplet mismatches are 49 and 33 at HLA-A/B versus HLA-DR. The tolerogenic factor ranges from −2176 to 1025.